Anti-inflammatory roles of IL-4 and IL-13 are well documented in the pathogenesis of psoriasis, type I diabetes, and experimental autoimmune encephalomyelitis (EAE)—the animal model of multiple sclerosis [45,46,47]. Here, IL13 is linked to psoriasis.